EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway

Yifan Zhu, Haidong He, Weiqian Sun, Jiajun Wu, Yong Xiao, Yinshun Peng, Ping Hu, Meiping Jin, Ping Liu, DongLiang Zhang, Ting Xie, Lusheng Huang und 5 weitere

Nephrology Dialysis Transplantation · 27.09.2024 · 39 (10) · 1624-1641

DOI: 10.1093/ndt/gfae052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 24.02.2024. Verfasst von Yifan Zhu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Minhang Hospital, Fudan University, Shanghai, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Glomerulonephritis, IGA, Immunoglobulin A, Signal Transduction. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation in Minhang District of Shanghai, Research project of Shanghai Minhang District Health Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunoglobulin A nephropathy (IgAN) is a major cause of primary glomerulonephritis characterized by mesangial deposits of galactose-deficient IgA1 (Gd-IgA1). Toll-like receptors (TLRs), particularly TLR4, are involved in the pathogenesis of IgAN. The role of gut microbiota on IgAN patients was recently investigated. However, whether gut microbial modifications of Gd-IgA1 through TLR4 play a role in IgAN remains unclear.

Methods

We recruited subjects into four groups, including 48 patients with untreated IgAN, 22 treated IgAN patients (IgANIT), 22 primary membranous nephropathy and 31 healthy controls (HCs). Fecal samples were collected to analyze changes in gut microbiome. Gd-IgA1 levels, expression of TLR4, B-cell stimulators and intestinal barrier function were evaluated in all subjects. C57BL/6 mice were treated with a broad-spectrum antibiotic cocktail to deplete the gut microbiota and then gavaged with fecal microbiota transplanted from clinical subjects of every group. Gd-IgA1 and TLR4 pathway were detected in peripheral blood mononuclear cells (PBMCs) from IgAN and HCs co-incubated with lipopolysaccharide (LPS) and TLR4 inhibitor.

Results

Compared with the other three groups, different compositions and decreased diversity demonstrated gut dysbiosis in the untreated IgAN group, especially the enrichment of Escherichia-Shigella. Elevated Gd-IgA1 levels were found in untreated IgAN patients and correlated with gut dysbiosis, TLR4, B-cell stimulators, indexes of intestinal barrier damage and proinflammatory cytokines. In vivo, mice colonized with gut microbiota from IgAN and IgANIT patients mimicked the IgAN phenotype with the activation of TLR4/MyD88/nuclear factor-κB pathway and B-cell stimulators in the intestine, and had with enhanced proinflammatory cytokines. In vitro, LPS activated TLR4/MyD88/NF-κB pathway, B-cell stimulators and proinflammatory cytokines in PBMCs of IgAN patients. This process may induce the overproduction of Gd-IgA1, which was inhibited by TLR4 inhibitors.

Conclusions

Our results illustrated that the gut–kidney axis is involved in the pathogenesis of IgAN. Gut dysbiosis could stimulate the overproduction of Gd-IgA1 via TLR4 signaling pathway production and B-cell stimulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeGlomerulonephritis, IGAImmunoglobulin ASignal TransductionToll-Like Receptor 4AdultAnimalsFemaleHumansMaleMiceMiddle AgedCase-Control StudiesMice, Inbred C57BL

Stichwörter der Autor:innen

Gd-IgA1IgA nephropathyTLR4 signaling pathwayfecal microbiota transplantationgut microbiome

Substanzen

Immunoglobulin ATLR4 protein, humanToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Nephrology, Minhang Hospital, Fudan University, Shanghai, P.R. China.
  • Department of Emergency, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.
  • School of Public Health, Fudan University, Shanghai, China.
  • Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Suzhou, P.R. China.
  • Department of Traditional Chinese Medicine, The First Affiliated Hospital of Soochow University, Jiangsu Suzhou, P.R. China.
  • Center for Traditional Chinese Medicine and Gut Microbiota, Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation in Minhang District of Shanghai
  • Research project of Shanghai Minhang District Health Committee
  • Minhang District High-Level Specialty Key Physician Training Program
  • Minhang District Medical Characteristic Specialty Project
  • Hospital-level Discipline-Chronic Disease Group-Chronic Kidney Disease Project
  • Jiangsu Provincial Medical Innovation Center

Zitieren

APA

Zhu, Y., He, H., Sun, W., Wu, J., Xiao, Y., Peng, Y., Hu, P., Jin, M., Liu, P., Zhang, D., Xie, T., Huang, L., He, W., Wei, M., Wang, L., Xu, X., & Tang, Y. (2024). IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation, 39(10), 1624-1641. https://doi.org/10.1093/ndt/gfae052

Vancouver

Zhu Y, He H, Sun W, Wu J, Xiao Y, Peng Y, et al. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway. Nephrology Dialysis Transplantation. 2024;39(10):1624-1641. doi:10.1093/ndt/gfae052

BibTeX
@article{Zhu2024,
  author = {Zhu, Yifan and He, Haidong and Sun, Weiqian and Wu, Jiajun and Xiao, Yong and Peng, Yinshun and Hu, Ping and Jin, Meiping and Liu, Ping and Zhang, DongLiang and Xie, Ting and Huang, Lusheng and He, Weiming and Wei, Minggang and Wang, Lishun and Xu, Xudong and Tang, Yuyan},
  title = {IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {10},
  pages = {1624--1641},
  doi = {10.1093/ndt/gfae052}
}
Kostenlos starten →